Raf kinase inhibitor protein (RKIP) as a novel predictor of molecular targeted therapies response in solid tumors
Raf kinase inhibitor protein (RKIP), was first described as an inhibitor of MAPK pathway, which accounts for its current name. However, subsequent studies have shown that…